Table 1.
Current Soft Tissue Replacement Strategies
| Current strategy | Advantages | Limitations | References |
|---|---|---|---|
| Autologous flaps | |||
| Superficial inferior epigastric artery | Autologous sources reduce host immune response | Transplant efficiency | 19,22–25 |
| Transverse rectus abdominis myocutaneous | Increased biocompatibility | Donor-site morbidity | |
| Deep inferior epigastric artery perforator | Long-term stability | ||
| Commercially available materials | |||
| ECM/tissue components | Act as filler for soft tissue defects | Mechanical integrity | 1,27,28 |
| Minerals/vegetable oils | Provide short-term solution | Volume loss with time | |
| Paraffin | Fibrous capsule contraction | ||
| Synthetic polymers | |||
| Silicone | |||
ECM, extracellular matrix.